The opportunity to follow in vivo, in a non invasive way, and at a molecular level, the effects of a drug in a living organism represents a noticeable breakthrough for the development of new treatments.
Quidd’s technologies are specifically adapted to each biological target in its in vivo context, allowing fully functional and optimized solutions. These fast and accurate techniques afford spatiotemporal, quantitative and highly reproducible results.
Offer
Unique optical probes families customizable
for your research
Each new biological model requires a different approach with a lot of problems to solve.
You can already visualize major biological disorders thanks to our smart probes portfolio targeted to:
- Caspase-3 activation in cell apoptosis (cardiovascular diseases, neurodegenerative diseases, cancer treatment efficacy …);
- MMPs activity correlated to tissue remodelling (cancer, fibrosis, arthritis…).
Additionally, Quidd fine tunes their offer by supplying you with all its know-how in optical molecular imaging and develops a custom-built offer: smart probes specially engineered to bring a unique solution to your specific problem.
Your R&D team therefore actively takes part to the elaboration of the characteristics of the desired probes, along with our team, until its final validation.
These optical probes, created on demand, can be used in vivo as well as for in vitro applications.
Here is a short list of biological events that can be treated thanks to Quidd’s technology:
- Protease,
- Phosphatase and Kinase activity,
- Glucose consumption,
- pH variation,
- Oxydo-reduction variation.
Powerfull small animal imagers that supply high quality data for in vivo tracking of your molecules
Completely oriented to your immediate and future needs, Quidd proposes upgrades according to the last technological or biological advances, making your investment fully perennial.
Top of page ^
Activity
Founded in 2003, Quidd is now established in France and North America. Our aim is to bring innovative and powerful tests for in vivo molecular imaging in preclinical and clinical applications: drug validation, early diagnosis and disease monitoring.
Quidd masters the complete optical molecular imaging chain: optical probe chemistry and dedicated imaging systems
Its multidisciplinary team of biologists, chemists and engineers allows to understand your goals and set up new solutions for in vivo optical imaging.
Quidd’s in-house expertise combined to key collaborations with academic partners in Europe and North America accelerate the development of innovative imaging tools.
Top of page ^
